Intellicheck Mobilisa, Inc. (NYSEMKT:IDN) belongs to Technology sector. Its weekly performance is -8.15%. On last trading day company shares ended up $1.24. Intellicheck Mobilisa, Inc. (NYSEMKT:IDN) distance from 50-day simple moving average (SMA50) is -14.15%. On 24 June, Intellicheck Mobilisa, Inc. (NYSE MKT:IDN), announced it has been awarded a US Patent for dynamic identity matching in response to threat levels. The new patent offers strong protection for the innovative technology underlying the Defense ID® and Law ID™ products relevant to real-time database queries and returning law enforcement-related information. The patent also has significant value for planned future product applications that deal with public safety, security and terrorism.
EnerJex Resources, Inc. (NYSEMKT:ENRJ) shares moved up 19.51% in last trading session and ended the day at $1.47. ENRJ Gross Margin is 45.40% and its return on assets is -21.10%. EnerJex Resources, Inc. (NYSEMKT:ENRJ) quarterly performance is -29.67%. EnerJex Resources, Inc. (NYSE MKT: ENRJ) announced that it has declared a monthly cash dividend on its non-convertible 10.0% Series A Cumulative Redeemable Perpetual Preferred Stock (“Series A Preferred Stock”). The dividend is for the month of July 2015 and is payable on July 31, 2015 to holders of record at the close of business on July 15, 2015.
On 10 July, Blucora, Inc. (NASDAQ:BCOR) shares moved up 1.48% and was closed at $15.74. BCOR EPS growth in last 5 year was -43.50%. Blucora, Inc. (NASDAQ:BCOR) year to date (YTD) performance is 13.65%. Zacks downgraded shares of Blucora (NASDAQ:BCOR) from a hold rating to a sell rating in a report issued on Tuesday, Analyst Ratings Network.com reports.
First West Virginia Bancorp Inc. (NYSEMKT:FWV) ended the last trading day at $20.45. Company weekly volatility is calculated as 2.39% and price to cash ratio as 1.46. First West Virginia Bancorp Inc. (NYSEMKT:FWV) showed a weekly performance of -8.09%.
Pfizer Inc. (NYSE:PFE) shares moved up 1.48% in last trading session and ended the day at $34.36. PFE Gross Margin is 81.00% and its return on assets is 6.80%. Pfizer Inc. (NYSE:PFE) quarterly performance is -2.25%. Pfizer Inc (NYSE:PFE) announced enrollment of the first patient in a phase 2b clinical trial of its investigational Staphylococcus aureus (S. aureus) multi-antigen vaccine (PF-06290510) in adults undergoing elective spinal fusion surgery.